Johns Hopkins ABX Guide
Zoliflodacin
INDICATIONS
FDA
FDA
- Zoliflodacin (Nuzolvence®) is approved for the treatment of uncomplicated urogenital gonorrhea due to Neisseria gonorrhoeae in adults and pediatric patients at least 12 years of age and who weigh at least 35 kg.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 17, 2026
Citation
Dzintars, Kathryn. "Zoliflodacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540808/all/Zoliflodacin.
Dzintars K. Zoliflodacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540808/all/Zoliflodacin. Accessed January 20, 2026.
Dzintars, K. (2026). Zoliflodacin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540808/all/Zoliflodacin
Dzintars K. Zoliflodacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 January 20]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540808/all/Zoliflodacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Zoliflodacin
ID - 540808
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2026/01/17/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540808/all/Zoliflodacin
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
